APO Research
Talk to an analyst

APO RESEARCH · REPORT

Felypressin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Felypressin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025198 pages

Choose your research edition.

Industry ResearchFelypressin Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Felypressin Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Felypressin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Felypressin Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Felypressin Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Felypressin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Felypressin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Felypressin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Felypressin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Felypressin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Felypressin include Peptide, WellMan, TargetMol, TaiTan, Maclin, Nanjing Peptide, Nanjing Leon, JunYu and AikonChem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Felypressin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Felypressin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Felypressin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Felypressin market size, projected growth trends, production technologies, key applications, and end-use industries.

Felypressin Segment by Company

Peptide

WellMan

TargetMol

TaiTan

Maclin

Nanjing Peptide

Nanjing Leon

JunYu

AikonChem

JuSheng

Sai Mannuo

Gotopbio

Mreda

Vulcanchem

Toronto Research Chemicals

Medical Isotopes

Glentham Life Sciences

Crysdot

ChemScene

CacheSyn

BOC Sciences

BIOTREND Chemicals AG

Felypressin Segment by Type

90% Purity

95% Purity

98% Purity

99% Purity

Felypressin Segment by Application

Medical

Health Products

Felypressin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Felypressin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Felypressin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Felypressin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Felypressin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Felypressin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Felypressin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Felypressin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Felypressin Industry Trends Table 2. Felypressin Industry Drivers Table 3. Felypressin Industry Opportunities and Challenges Table 4. Felypressin Industry Restraints Table 5. Global Felypressin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Felypressin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Felypressin Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Felypressin Sales Market Share by Manufacturers Table 9. Global Felypressin Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Felypressin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Felypressin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Felypressin Manufacturers, Product Type & Application Table 13. Global Felypressin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Felypressin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 90% Purity Table 17. Major Manufacturers of 95% Purity Table 18. Major Manufacturers of 98% Purity Table 19. Major Manufacturers of 99% Purity Table 20. Global Felypressin Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 21. Global Felypressin Sales by Type (2021-2026) & (Tons) Table 22. Global Felypressin Sales by Type (2027-2032) & (Tons) Table 23. Global Felypressin Sales Market Share by Type (2021-2026) Table 24. Global Felypressin Sales Market Share by Type (2027-2032) Table 25. Global Felypressin Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 26. Global Felypressin Revenue by Type (2021-2026) & (Tons) Table 27. Global Felypressin Revenue by Type (2027-2032) & (Tons) Table 28. Global Felypressin Revenue Market Share by Type (2021-2026) Table 29. Global Felypressin Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Medical Table 31. Major Manufacturers of Health Products Table 32. Global Felypressin Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 33. Global Felypressin Sales by Application (2021-2026) & (Tons) Table 34. Global Felypressin Sales by Application (2027-2032) & (Tons) Table 35. Global Felypressin Sales Market Share by Application (2021-2026) Table 36. Global Felypressin Sales Market Share by Application (2027-2032) Table 37. Global Felypressin Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 38. Global Felypressin Revenue by Application (2021-2026) & (Tons) Table 39. Global Felypressin Revenue by Application (2027-2032) & (Tons) Table 40. Global Felypressin Revenue Market Share by Application (2021-2026) Table 41. Global Felypressin Revenue Market Share by Application (2027-2032) Table 42. Global Felypressin Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 43. Global Felypressin Sales by Region (2021-2026) & (Tons) Table 44. Global Felypressin Sales Market Share by Region (2021-2026) Table 45. Global Felypressin Sales Forecasted by Region (2027-2032) & (Tons) Table 46. Global Felypressin Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Felypressin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 48. North America Felypressin Sales by Country (2021-2026) & (Tons) Table 49. North America Felypressin Sales by Country (2027-2032) & (Tons) Table 50. Europe Felypressin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 51. Europe Felypressin Sales by Country (2021-2026) & (Tons) Table 52. Europe Felypressin Sales by Country (2027-2032) & (Tons) Table 53. Asia Pacific Felypressin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 54. Asia Pacific Felypressin Sales by Country (2021-2026) & (Tons) Table 55. Asia Pacific Felypressin Sales by Country (2027-2032) & (Tons) Table 56. South America, Middle East and Africa Felypressin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 57. South America, Middle East and Africa Felypressin Sales by Country (2021-2026) & (Tons) Table 58. South America, Middle East and Africa Felypressin Sales by Country (2027-2032) & (Tons) Table 59. Global Felypressin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Felypressin Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Felypressin Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Felypressin Revenue Market Share by Region (2021-2026) Table 63. Global Felypressin Revenue Market Share by Region (2027-2032) Table 64. Peptide Company Information Table 65. Peptide Business Overview Table 66. Peptide Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Peptide Felypressin Product Portfolio Table 68. Peptide Recent Development Table 69. WellMan Company Information Table 70. WellMan Business Overview Table 71. WellMan Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. WellMan Felypressin Product Portfolio Table 73. WellMan Recent Development Table 74. TargetMol Company Information Table 75. TargetMol Business Overview Table 76. TargetMol Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. TargetMol Felypressin Product Portfolio Table 78. TargetMol Recent Development Table 79. TaiTan Company Information Table 80. TaiTan Business Overview Table 81. TaiTan Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. TaiTan Felypressin Product Portfolio Table 83. TaiTan Recent Development Table 84. Maclin Company Information Table 85. Maclin Business Overview Table 86. Maclin Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Maclin Felypressin Product Portfolio Table 88. Maclin Recent Development Table 89. Nanjing Peptide Company Information Table 90. Nanjing Peptide Business Overview Table 91. Nanjing Peptide Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Nanjing Peptide Felypressin Product Portfolio Table 93. Nanjing Peptide Recent Development Table 94. Nanjing Leon Company Information Table 95. Nanjing Leon Business Overview Table 96. Nanjing Leon Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Nanjing Leon Felypressin Product Portfolio Table 98. Nanjing Leon Recent Development Table 99. JunYu Company Information Table 100. JunYu Business Overview Table 101. JunYu Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. JunYu Felypressin Product Portfolio Table 103. JunYu Recent Development Table 104. AikonChem Company Information Table 105. AikonChem Business Overview Table 106. AikonChem Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. AikonChem Felypressin Product Portfolio Table 108. AikonChem Recent Development Table 109. JuSheng Company Information Table 110. JuSheng Business Overview Table 111. JuSheng Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. JuSheng Felypressin Product Portfolio Table 113. JuSheng Recent Development Table 114. Sai Mannuo Company Information Table 115. Sai Mannuo Business Overview Table 116. Sai Mannuo Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Sai Mannuo Felypressin Product Portfolio Table 118. Sai Mannuo Recent Development Table 119. Gotopbio Company Information Table 120. Gotopbio Business Overview Table 121. Gotopbio Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Gotopbio Felypressin Product Portfolio Table 123. Gotopbio Recent Development Table 124. Mreda Company Information Table 125. Mreda Business Overview Table 126. Mreda Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Mreda Felypressin Product Portfolio Table 128. Mreda Recent Development Table 129. Vulcanchem Company Information Table 130. Vulcanchem Business Overview Table 131. Vulcanchem Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Vulcanchem Felypressin Product Portfolio Table 133. Vulcanchem Recent Development Table 134. Toronto Research Chemicals Company Information Table 135. Toronto Research Chemicals Business Overview Table 136. Toronto Research Chemicals Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Toronto Research Chemicals Felypressin Product Portfolio Table 138. Toronto Research Chemicals Recent Development Table 139. Medical Isotopes Company Information Table 140. Medical Isotopes Business Overview Table 141. Medical Isotopes Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Medical Isotopes Felypressin Product Portfolio Table 143. Medical Isotopes Recent Development Table 144. Glentham Life Sciences Company Information Table 145. Glentham Life Sciences Business Overview Table 146. Glentham Life Sciences Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Glentham Life Sciences Felypressin Product Portfolio Table 148. Glentham Life Sciences Recent Development Table 149. Crysdot Company Information Table 150. Crysdot Business Overview Table 151. Crysdot Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Crysdot Felypressin Product Portfolio Table 153. Crysdot Recent Development Table 154. ChemScene Company Information Table 155. ChemScene Business Overview Table 156. ChemScene Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. ChemScene Felypressin Product Portfolio Table 158. ChemScene Recent Development Table 159. CacheSyn Company Information Table 160. CacheSyn Business Overview Table 161. CacheSyn Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. CacheSyn Felypressin Product Portfolio Table 163. CacheSyn Recent Development Table 164. BOC Sciences Company Information Table 165. BOC Sciences Business Overview Table 166. BOC Sciences Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 167. BOC Sciences Felypressin Product Portfolio Table 168. BOC Sciences Recent Development Table 169. BIOTREND Chemicals AG Company Information Table 170. BIOTREND Chemicals AG Business Overview Table 171. BIOTREND Chemicals AG Felypressin Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 172. BIOTREND Chemicals AG Felypressin Product Portfolio Table 173. BIOTREND Chemicals AG Recent Development Table 174. Key Raw Materials Table 175. Raw Materials Key Suppliers Table 176. Felypressin Distributors List Table 177. Felypressin Customers List Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources Table 181. Primary Sources List of Figures Figure 1. Felypressin Product Image Figure 2. Global Felypressin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Felypressin Market Size (2021-2032) & (US$ Million) Figure 4. Global Felypressin Sales (2021-2032) & (Tons) Figure 5. Global Felypressin Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Felypressin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 90% Purity Image Figure 9. 95% Purity Image Figure 10. 98% Purity Image Figure 11. 99% Purity Image Figure 12. Global Felypressin Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Felypressin Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Felypressin Sales Market Share by Type (2021-2032) Figure 15. Global Felypressin Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 16. Global Felypressin Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Felypressin Revenue Market Share by Type (2021-2032) Figure 18. Medical Image Figure 19. Health Products Image Figure 20. Global Felypressin Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 21. Global Felypressin Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Felypressin Sales Market Share by Application (2021-2032) Figure 23. Global Felypressin Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 24. Global Felypressin Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Felypressin Revenue Market Share by Application (2021-2032) Figure 26. North America Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 27. North America Felypressin Sales Market Share by Country (2021-2032) Figure 28. U.S. Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 29. Canada Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 30. Mexico Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 31. Europe Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 32. Europe Felypressin Sales Market Share by Country (2021-2032) Figure 33. Germany Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 34. France Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 35. U.K. Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 36. Italy Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Netherlands Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 38. Asia Pacific Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 39. Asia Pacific Felypressin Sales Market Share by Country (2021-2032) Figure 40. China Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 41. Japan Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 42. South Korea Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 43. Southeast Asia Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 44. India Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 45. Australia Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 46. South America, Middle East and Africa Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 47. South America, Middle East and Africa Felypressin Sales Market Share by Country (2021-2032) Figure 48. Brazil Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 49. South Africa Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 50. Saudi Arabia Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 51. Turkey Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 52. Argentina Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 53. UAE Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 54. Egypt Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 55. Chile Felypressin Sales and Growth Rate (2021-2032) & (Tons) Figure 56. Global Felypressin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Felypressin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Felypressin Revenue (2021-2032) & (US$ Million) Figure 59. North America Felypressin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Felypressin Revenue (2021-2032) & (US$ Million) Figure 61. Europe Felypressin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Felypressin Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Felypressin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Felypressin Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Felypressin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Felypressin Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Felypressin Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 90% Purity
  • 95% Purity
  • 98% Purity
  • 99% Purity
Applications
  • Medical
  • Health Products
Companies covered
  • Peptide
  • WellMan
  • TargetMol
  • TaiTan
  • Maclin
  • Nanjing Peptide
  • Nanjing Leon
  • JunYu
  • AikonChem
  • JuSheng
  • Sai Mannuo
  • Gotopbio
  • Mreda
  • Vulcanchem
  • Toronto Research Chemicals
  • Medical Isotopes
  • Glentham Life Sciences
  • Crysdot
  • ChemScene
  • CacheSyn
  • BOC Sciences
  • BIOTREND Chemicals AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Felypressin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Felypressin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Felypressin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Felypressin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Felypressin Market Dynamics
  1. 2.1 Felypressin Industry Trends
  2. 2.2 Felypressin Industry Drivers
  3. 2.3 Felypressin Industry Opportunities and Challenges
  4. 2.4 Felypressin Industry Restraints
3 Felypressin Market by Manufacturers
  1. 3.1 Global Felypressin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Felypressin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Felypressin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Felypressin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Felypressin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Felypressin Manufacturers, Product Type & Application
  7. 3.7 Global Felypressin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Felypressin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Felypressin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Felypressin Tier 1, Tier 2, and Tier 3
4 Felypressin Market by Type
  1. 4.1 Felypressin Type Introduction
  2. 4.1.1 90% Purity
  3. 4.1.2 95% Purity
  4. 4.1.3 98% Purity
  5. 4.1.4 99% Purity
  6. 4.2 Global Felypressin Sales by Type
  7. 4.2.1 Global Felypressin Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Felypressin Sales by Type (2021-2032)
  9. 4.2.3 Global Felypressin Sales Market Share by Type (2021-2032)
  10. 4.3 Global Felypressin Revenue by Type
  11. 4.3.1 Global Felypressin Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Felypressin Revenue by Type (2021-2032)
  13. 4.3.3 Global Felypressin Revenue Market Share by Type (2021-2032)
5 Felypressin Market by Application
  1. 5.1 Felypressin Application Introduction
  2. 5.1.1 Medical
  3. 5.1.2 Health Products
  4. 5.2 Global Felypressin Sales by Application
  5. 5.2.1 Global Felypressin Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Felypressin Sales by Application (2021-2032)
  7. 5.2.3 Global Felypressin Sales Market Share by Application (2021-2032)
  8. 5.3 Global Felypressin Revenue by Application
  9. 5.3.1 Global Felypressin Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Felypressin Revenue by Application (2021-2032)
  11. 5.3.3 Global Felypressin Revenue Market Share by Application (2021-2032)
6 Global Felypressin Sales by Region
  1. 6.1 Global Felypressin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Felypressin Sales by Region (2021-2032)
  3. 6.2.1 Global Felypressin Sales by Region (2021-2026)
  4. 6.2.2 Global Felypressin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Felypressin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Felypressin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Felypressin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Felypressin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Felypressin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Felypressin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Felypressin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Felypressin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Felypressin Revenue by Region
  1. 7.1 Global Felypressin Revenue by Region
  2. 7.1.1 Global Felypressin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Felypressin Revenue by Region (2021-2026)
  4. 7.1.3 Global Felypressin Revenue by Region (2027-2032)
  5. 7.1.4 Global Felypressin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Felypressin Revenue (2021-2032)
  8. 7.2.2 North America Felypressin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Felypressin Revenue (2021-2032)
  11. 7.3.2 Europe Felypressin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Felypressin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Felypressin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Felypressin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Felypressin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Peptide
  2. 8.1.1 Peptide Company Information
  3. 8.1.2 Peptide Business Overview
  4. 8.1.3 Peptide Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Peptide Felypressin Product Portfolio
  6. 8.1.5 Peptide Recent Developments
  7. 8.2 WellMan
  8. 8.2.1 WellMan Company Information
  9. 8.2.2 WellMan Business Overview
  10. 8.2.3 WellMan Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 WellMan Felypressin Product Portfolio
  12. 8.2.5 WellMan Recent Developments
  13. 8.3 TargetMol
  14. 8.3.1 TargetMol Company Information
  15. 8.3.2 TargetMol Business Overview
  16. 8.3.3 TargetMol Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 TargetMol Felypressin Product Portfolio
  18. 8.3.5 TargetMol Recent Developments
  19. 8.4 TaiTan
  20. 8.4.1 TaiTan Company Information
  21. 8.4.2 TaiTan Business Overview
  22. 8.4.3 TaiTan Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 TaiTan Felypressin Product Portfolio
  24. 8.4.5 TaiTan Recent Developments
  25. 8.5 Maclin
  26. 8.5.1 Maclin Company Information
  27. 8.5.2 Maclin Business Overview
  28. 8.5.3 Maclin Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Maclin Felypressin Product Portfolio
  30. 8.5.5 Maclin Recent Developments
  31. 8.6 Nanjing Peptide
  32. 8.6.1 Nanjing Peptide Company Information
  33. 8.6.2 Nanjing Peptide Business Overview
  34. 8.6.3 Nanjing Peptide Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Nanjing Peptide Felypressin Product Portfolio
  36. 8.6.5 Nanjing Peptide Recent Developments
  37. 8.7 Nanjing Leon
  38. 8.7.1 Nanjing Leon Company Information
  39. 8.7.2 Nanjing Leon Business Overview
  40. 8.7.3 Nanjing Leon Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nanjing Leon Felypressin Product Portfolio
  42. 8.7.5 Nanjing Leon Recent Developments
  43. 8.8 JunYu
  44. 8.8.1 JunYu Company Information
  45. 8.8.2 JunYu Business Overview
  46. 8.8.3 JunYu Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 JunYu Felypressin Product Portfolio
  48. 8.8.5 JunYu Recent Developments
  49. 8.9 AikonChem
  50. 8.9.1 AikonChem Company Information
  51. 8.9.2 AikonChem Business Overview
  52. 8.9.3 AikonChem Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 AikonChem Felypressin Product Portfolio
  54. 8.9.5 AikonChem Recent Developments
  55. 8.10 JuSheng
  56. 8.10.1 JuSheng Company Information
  57. 8.10.2 JuSheng Business Overview
  58. 8.10.3 JuSheng Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 JuSheng Felypressin Product Portfolio
  60. 8.10.5 JuSheng Recent Developments
  61. 8.11 Sai Mannuo
  62. 8.11.1 Sai Mannuo Company Information
  63. 8.11.2 Sai Mannuo Business Overview
  64. 8.11.3 Sai Mannuo Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sai Mannuo Felypressin Product Portfolio
  66. 8.11.5 Sai Mannuo Recent Developments
  67. 8.12 Gotopbio
  68. 8.12.1 Gotopbio Company Information
  69. 8.12.2 Gotopbio Business Overview
  70. 8.12.3 Gotopbio Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Gotopbio Felypressin Product Portfolio
  72. 8.12.5 Gotopbio Recent Developments
  73. 8.13 Mreda
  74. 8.13.1 Mreda Company Information
  75. 8.13.2 Mreda Business Overview
  76. 8.13.3 Mreda Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Mreda Felypressin Product Portfolio
  78. 8.13.5 Mreda Recent Developments
  79. 8.14 Vulcanchem
  80. 8.14.1 Vulcanchem Company Information
  81. 8.14.2 Vulcanchem Business Overview
  82. 8.14.3 Vulcanchem Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Vulcanchem Felypressin Product Portfolio
  84. 8.14.5 Vulcanchem Recent Developments
  85. 8.15 Toronto Research Chemicals
  86. 8.15.1 Toronto Research Chemicals Company Information
  87. 8.15.2 Toronto Research Chemicals Business Overview
  88. 8.15.3 Toronto Research Chemicals Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Toronto Research Chemicals Felypressin Product Portfolio
  90. 8.15.5 Toronto Research Chemicals Recent Developments
  91. 8.16 Medical Isotopes
  92. 8.16.1 Medical Isotopes Company Information
  93. 8.16.2 Medical Isotopes Business Overview
  94. 8.16.3 Medical Isotopes Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Medical Isotopes Felypressin Product Portfolio
  96. 8.16.5 Medical Isotopes Recent Developments
  97. 8.17 Glentham Life Sciences
  98. 8.17.1 Glentham Life Sciences Company Information
  99. 8.17.2 Glentham Life Sciences Business Overview
  100. 8.17.3 Glentham Life Sciences Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Glentham Life Sciences Felypressin Product Portfolio
  102. 8.17.5 Glentham Life Sciences Recent Developments
  103. 8.18 Crysdot
  104. 8.18.1 Crysdot Company Information
  105. 8.18.2 Crysdot Business Overview
  106. 8.18.3 Crysdot Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Crysdot Felypressin Product Portfolio
  108. 8.18.5 Crysdot Recent Developments
  109. 8.19 ChemScene
  110. 8.19.1 ChemScene Company Information
  111. 8.19.2 ChemScene Business Overview
  112. 8.19.3 ChemScene Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 ChemScene Felypressin Product Portfolio
  114. 8.19.5 ChemScene Recent Developments
  115. 8.20 CacheSyn
  116. 8.20.1 CacheSyn Company Information
  117. 8.20.2 CacheSyn Business Overview
  118. 8.20.3 CacheSyn Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 CacheSyn Felypressin Product Portfolio
  120. 8.20.5 CacheSyn Recent Developments
  121. 8.21 BOC Sciences
  122. 8.21.1 BOC Sciences Company Information
  123. 8.21.2 BOC Sciences Business Overview
  124. 8.21.3 BOC Sciences Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 BOC Sciences Felypressin Product Portfolio
  126. 8.21.5 BOC Sciences Recent Developments
  127. 8.22 BIOTREND Chemicals AG
  128. 8.22.1 BIOTREND Chemicals AG Company Information
  129. 8.22.2 BIOTREND Chemicals AG Business Overview
  130. 8.22.3 BIOTREND Chemicals AG Felypressin Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 BIOTREND Chemicals AG Felypressin Product Portfolio
  132. 8.22.5 BIOTREND Chemicals AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Felypressin Value Chain Analysis
  2. 9.1.1 Felypressin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Felypressin Production Mode & Process
  6. 9.2 Felypressin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Felypressin Distributors
  9. 9.2.3 Felypressin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst